SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Bayer CropScience surges on reporting 19% rise in Q1 net profit

09 Aug 2016 Evaluate

Bayer CropScience is currently trading at Rs. 4057.05, up by 56.35 points or 1.41% from its previous closing of Rs. 4000.70 on the BSE.

The scrip opened at Rs. 4030.00 and has touched a high and low of Rs. 4080.00 and Rs. 4030.00 respectively. So far 415 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 4155.00 on 12-May-2016 and a 52 week low of Rs. 3115.00 on 12-Feb-2016.

Last one week high and low of the scrip stood at Rs. 4105.00 and Rs. 3972.00 respectively. The current market cap of the company is Rs. 14346.65 crore.

The promoters holding in the company stood at 68.58%, while institutions and non-institutions held 19.85% and 11.57% respectively.

Bayer CropScience has reported 18.63% rise in its net profit at Rs 131.20 crore for the quarter as compared to Rs 110.60 crore for the same quarter in the previous year. Total income of the company increased by 6.10% at Rs 874.80 crore for quarter under review as compared to Rs 824.50 crore for the quarter ended June 30, 2015.

Bayer CropScience is engaged in manufacturing and marketing of crop-protection solutions, and trades in seeds on behalf of group company Bayer Bioscience.

Bayer CropScience Share Price

4900.45 -32.85 (-0.67%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
UPL 665.00
PI Industries 3144.45
Bayer CropScience 4900.45
Sharda Cropchem 1109.70
Sumitomo Chemical 441.95
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×